Topotarget merger clears final hurdles
The merger between Topotarget and BioAlliance Pharma is now a reality after shareholders from both companies have given it the thumbs up.
by Benjamin Werner Christensen
The merger between BioAlliance Pharma and Topotarget is now – quite as expected – a reality. Shareholders from both companies have given their blessing for the union, Topotarget writes in a press release.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
